Search Within

Sloan Kettering Institute Faculty

  1. "Molecular Therapy"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (23)
Groups
  1. GSK Faculty (70)
  2. Molecular Pharmacology and Chemistry Program Faculty (67)
  3. Department of Medicine (65)
  4. Center for Hematologic Malignancies (63)
  5. Hematologic Malignancies, Division of (63)
  6. Hematologic Malignancies Research (61)

More Groups

People
  1. Michel Sadelain (56)
  2. Isabelle Riviere (32)
  3. Renier Brentjens (14)
  4. Xiuyan Wang (14)
  5. Jorge Mansilla-Soto (11)
  6. Jae Park (7)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. Molecular Therapy (72)
Publishers
  1. Nature Publishing Group (72)

Results (72)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Repair of the sickle-cell disease mutation in human stem cells using CRISPR/Cas9 and single-stranded oligodeoxynucleotides
    Meeting Abstract

    Mansilla-Soto, J.; Leyfman, Y.; Sadelain, M.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Activation signals from CD19-CAR permit NFAT-controlled inducible expression of transgenes in PBMCs
    Meeting Abstract

    Uchibori, R.; Teruya, T.; Ninomiya, S.; Ido, H.; Tsukahara, T.; Ohmine, K.; Urabe, M.; Saga, Y.; Kume, A.; Mizukami, H.; more...
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Optimal activation of both CD28 and 4-1BB in CAR-targeted T cells results in enhanced tumor eradication
    Meeting Abstract

    Zhao, Z.; Van Der Stegen, S. J. C.; Condomines, M.; Perna, F.; Gunset, G.; Plotkin, J.; Sadelain, M.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • ASGCT and JSGT joint position statement on human genomic editing
    Journal Article

    Friedmann, T.; Jonlin, E. C.; King, N. M. P.; Torbett, B. E.; Wivel, N. A.; Kaneda, Y.; Sadelain, M.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Genome editing technologies: Defining a path to clinic
    Journal Article

    Corrigan-Curay, J.; O'Reilly, M.; Kohn, D. B.; Cannon, P. M.; Bao, G.; Bushman, F. D.; Carroll, D.; Cathomen, T.; Joung, J. K.; Roth, D.; more...
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • T-cell immunotherapy: Looking forward
    Journal Article

    Corrigan-Curay, J.; Kiem, H. P.; Baltimore, D.; O'Reilly, M.; Brentjens, R. J.; Cooper, L.; Forman, S.; Gottschalk, S.; Greenberg, P.; Junghans, R.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer
    Meeting Abstract

    Xie, Y.; Hicks, M. J.; Kaminsky, S. M.; Moore, M. A. S.; Crystal, R. G.; Rafii, A.
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Development of inducible switch promoters that drive exogenous gene expression upon the recognition of CD19 by chimeric antigen receptors
    Meeting Abstract

    Uchibori, R.; Ninomiya, S.; Tsukahara, T.; Ido, H.; Teruya, T.; Omine, K.; Urabe, M.; Mizukami, H.; Kume, A.; Riviere, I.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • beta-Globin gene editing in human cells using TALENs and ssDNA oligonucleotides: Towards a gene repair approach for sickle cell anemia and beta-thalassemias
    Meeting Abstract

    Mansilla-Soto, J.; Socci, N.; Leyfman, Y.; Sadelain, M.
    Molecular Therapy (2014)

    Fulltext@MSK | Save